Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time
- 1 November 2005
- journal article
- Published by Elsevier in Kidney International
- Vol. 68 (5) , 2323-2330
- https://doi.org/10.1111/j.1523-1755.2005.00693.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hemoglobin Targets for the Anemia of Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2004
- Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patientsKidney International, 2004
- Hemoglobin variability in epoetin-treated hemodialysis patientsKidney International, 2003
- The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patientsKidney International, 2003
- Should Hemoglobin be Normalized in Patients with Chronic Kidney Disease?Seminars in Dialysis, 2002
- The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis studyKidney International, 2000
- A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study)American Journal of Kidney Diseases, 1999
- Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac diseaseKidney International, 1999
- Normalizing hematocrit in dialysis patients improves brain functionAmerican Journal of Kidney Diseases, 1999
- Biases in Prevalent CohortsBiometrics, 1987